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ABSTRACT
The DNA damage-responsive protein kinases ATM
and ATR phosphorylate SQ/TQ motifs that lie in
clusters in most of their in vivo targets. Budding
yeast Cdc13p contains two clusters of SQ/TQ
motifs, suggesting that it might be a target of
Mec1p/Tel1p (yeast ATR/ATM). Here we demon-
strated that the telomerase recruitment domain of
Cdc13p is phosphorylated by Mec1p and Tel1p. Gel
analysis showed that Cdc13p contains a Mec1/Tel1-
dependent post-translational modification. Using an
immunoprecipitate (IP)-kinase assay, we showed
that Mec1p phosphorylates Cdc13p on serine 225,
249, 255 and 306, and Tel1p phosphorylates Cdc13p
on serine 225, 249 and 255 in vitro. Phenotypic
analysis in vivo revealed that the mutations in the
Cdc13p SQ motifs phosphorylated by Mec1p and
Tel1p caused multiple telomere and growth defects.
In addition, normal telomere length and growth
could be restored by expressing a Cdc13–Est1p
hybrid protein. These results demonstrate the
telomerase recruitment domain of Cdc13p as an
important new telomere-specific target of Mec1p/
Tel1p.
INTRODUCTION
Telomeres are dynamic DNA–protein complexes that protect
the ends of linear chromosomes, prevent detrimental chromo-
some rearrangements and defend against genomic instability
and the associated risk of cancer (1–3). Telomeres, consisting
of tandem repeats of short G-rich sequences, are synthesized
by the enzyme telomerase (4,5). The catalytic core of telom-
erase is composed of a reverse transcriptase and an RNA sub-
unit. The reverse transcriptase utilizes the RNA component as
a template to add the G-rich repeats onto the 30 ends of the
chromosome (4–6). In most human somatic cells, telomerase
activity is absent, and telomeres are gradually shortened with
successive cell divisions due to incomplete replication, which
eventually causes replicative senescence. Once telomeres
become sufﬁciently short, they are thought to lose the ability
to protect the ends of the chromosomes from being recog-
nized as broken ends, and being subjected to nuclease diges-
tion and active recombinational repair. Continuous telomere
shortening in human ﬁbroblasts leads to chromosome fusions,
crisis and apoptosis (7). Very few human cells can bypass the
crisis either through telomerase reactivation or through an
alternative recombination pathway for telomere lengthening
(8–10).
In budding yeast Saccharomyces cerevisiae, several genes
encoding components of the telomerase enzyme have been
identiﬁed and mutations in these genes cause a gradual loss
of telomere length (11,12). EST2 and TLC1 encode the
reverse transcriptase catalytic protein subunit and the tem-
plating RNA, respectively (12–14). In addition, the protein
encoded by EST1 is associated with the RNA component of
telomerase and is bound to single-stranded telomeric DNA
in vitro (15–18). Other accessory factors, such as Cdc13p,
are required for the in vivo action of telomerase. Cdc13p is
a single-strand telomere binding protein (19–23). Studies of
different alleles of CDC13 revealed that Cdc13p is involved
in both telomere protection and telomerase recruitment
(21,24–26). A mutation allele of cdc13, cdc13-2 (a
Glu252!Lys change), causes a gradual loss of telomere
length (21) whereas a truncated form of cdc13, cdc13-5 (an
N-terminal amino acids 1–694 fragment of Cdc13p), has
long telomeres (25). Genetic and physical interactions were
also observed between CDC13 and EST1 (21,24,27). There-
fore, Cdc13p may cooperate with Est1p to recruit telomerase
to telomeres or activate telomere-bound telomerase for its
replication (22,28).
Ineukaryotes,themaintenanceofgenomeintegrityrelieson
a set of surveillance systems, called checkpoints. These check-
points are responsible for proper detection and repair of DNA
damage caused by environmental stresses or irregularities
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are recognized by the putative protein complex containing
protein kinases such as human ATM and ATR (ATM-related),
and ﬁssion yeast Schizosaccharomyces pombe Rad3 (29).
S.cerevisiae MEC1 and TEL1 are homologous to the
human ATR and ATM, respectively (30). Mec1p and
Tel1p function upstream in the checkpoint pathway by phos-
phorylation of serine and threonine residues in the context
of SQ or TQ motifs (31). Mec1p and Tel1p are important
regulators of a group of proteins that detect, signal and
repair DNA damage (32,33). Interestingly, the loss of
Mec1p results in a modest decrease in telomere length,
while telomeres are very short but stable in a tel1 strain.
Cells lacking both TEL1 and MEC1 have very short telom-
eres and undergo senescence similar to that observed in
telomerase-deﬁcient cells (34,35). Furthermore, telomerase
activation requires the ATM kinase functions in humans,
S.cerevisiae and S.pombe (35–39). These results suggest
that proteins involved in DNA damage checkpoints may
play a role in telomere replication.
We previously showed that CDC13, MEC1 and TEL1 are
all involved in telomere–telomere recombination (40). In
this study, we demonstrate that Cdc13p is an in vivo target
of Mec1/Tel1 kinases. The telomerase recruitment domain
of Cdc13p is a direct substrate for the Mec1/Tel1 kinase as
evident by the immunoprecipitate (IP)-kinase assay. Phos-
phorylation sites on Cdc13p were identiﬁed and the telomeric
phenotypes of yeast strains carrying mutations on the phos-
phorylation sites were examined.
MATERIALS AND METHODS
Strains, plasmids, yeast and telomere experiments
All the yeast operations were performed by standard methods
(41). Yeast strains used in the study were derivatives of
YPH501 (MATa/MATaA ura3-52/ura3-52 lys2-801 amber/
lys2-801 amber ade2-101 ochre/ade2-101 ochre trp1aD63/
trp1aD63 his3aD200/his3aD200 leu2-aD1/leu2-aD1). The
yeast strains carrying mec1, sml1, tel1, cdc13 and CDC13-
Myc9 were described previously (15,23,40). YEp24CDC13-
URA3 was constructed as previously described (26).
pRS314CDC13, pRS304cdc13 and pRS304cdc13-Myc9
were obtained from Dr Virginia Zakian (23,27). The 1 kb
SacII fragment from pRS304cdc13-Myc9 was inserted into
the SacII-digested pRS314CDC13 to make pRS314CDC13-
Myc9. Point mutations were introduced into the CDC13
using QuikChange site-directed mutagenesis (Stratagene).
To generate chromosomal cdc13 mutants, pRS304cdc13
mutants were XhoI-digested and transformed into CDC13
strains. pVT1091 (pCDC13-EST1) plasmid (28) was kindly
provided by Dr Victoria Lundblad. To generate pVL1091
mutant plasmids, the 1.4 kb BamHI–StuI fragments in
pRS314CDC13-AA or pRS314CDC13-EE mutants were
cloned into the BamHI–StuI-digested pVT1091. We carried
out cellular senescence assays as described (40). All primer
sequences for PCR and mutagenesis are available upon
request. Telomere blot analysis and serial liquid dilutions
were performed as described previously (42,43). Cultures
were inoculated directly from the FOA plate into 10 ml of liq-
uid YEPD medium and allowed to grow to stationary phase
on a 30 C roller drum. The cultures were diluted repeatedly
1:10000 into fresh medium for 48 or 72 h for six times.
Data shown here are representatives of three or more experi-
ments from independent colonies.
Immunoprecipitation, gel electrophoresis
and western blot analysis
To detect Cdc13p, cells were grown in YPD broth. Whole
cell proteins were extracted and resolved by SDS–PAGE as
described previously (44). Cdc13 protein was detected with
an anti-Myc antibody (Santa Cruz Biotechnology). Immuno-
precipitation of Cdc13-Myc was done with agarose-
conjugated 9E10 monoclonal antibodies (sc-40; Santa Cruz
Biotechnology). For 2D gel electrophoresis separations,
immunoprecipitated proteins were denatured in 2D sample
buffer (7 M Urea, 2 M Urea, 4% CHAPS, 1% DTT and
2% IPG buffer). Proteins were separated by isoelectric focus-
ing using the IPGphor apparatus (Amersham Biosciences)
and active in-gel rehydration as described on immobilized
linear pH gradient (IPG, pH 4–7) strips (Amersham Bio-
sciences). Isoelectric focusing was performed for a total of
30 000 Vh, starting at 200 V and gradually raising the voltage
to 5000 V. The IPG strip was then equilibrated for 15 min in
50 mM Tris (pH 8.8), 6 M urea, 30% glycerol, 1% SDS and
1% DTT, and for 20 min in 50 mM Tris, 6 M urea, 30% glyc-
erol, 1% SDS and 5% iodoacetamide before loading on to
SDS–polyacrylamide slab gels (5%) for separation according
to molecular mass.
Phosphatase treatment of immune complexes of Cdc13p
Agarose-bound Cdc13p immunocomplexes were additionally
washed twice with basic phosphatase buffer (50 mM Tris–
HCl, pH 7.5, 5 mM DTT and 2 mM MnCl2) and then incu-
bated with 100 units of calf intestinal phosphatase (New Eng-
land Biolabs) for 30 min at 30 C. The reaction was stopped
by addition of ice-cold basic kinase buffer containing
10 mM Na3VO4 and 10 mM NaF. Phosphatase-treated
immune complexes were washed twice with basic kinase
buffer and used in kinase assays as described below.
Recombinant protein purification
Plasmid pGEX-4TCDC13(129–332) was constructed by lig-
ating a HindIII–Klenow fragment containing amino acids
129–332 of Cdc13 from pRS314CDC13 into BamHI–Klenow
treated pGEX-4T (Amersham/Pharmercia). Plasmid pGEX-
4TCDC13(570–676) was constructed by ligating a PCR prod-
uct containing amino acids 570–676 of Cdc13 from
pRS314CDC13 into BamHI–Klenow and XhoI treated
pGEX-4T. Plasmid pET28cCDC13(185–332) was con-
structed by ligating a BamHI–Klenow and NotI treated frag-
ment containing amino acids 185–332 of Cdc13p from
pGEX-4TCDC13(129–332) into pET28a (Novagen) with
the same sites. Plasmid pGEX-4TCDC13(185–332) was con-
structed by ligating a NcoI–Klenow and XhoI-treated frag-
ment containing amino acids 185–332 of Cdc13p from
pET28cCDC13(129–332) into BamHI–Klenow and XhoI-
treated pGEX-4T. Plasmid pGEX-4TCDC13(276–332) was
constructed by self-ligating the BamHI–NsiI–Klenow frag-
ment of pGEX-4TCDC13(185–332) backbone. Plasmid
pGEX-4TCDC13(185–275) was constructed by self-ligating
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332) backbone. Recombinant proteins in E.coli were over-
expressed and puriﬁed as described by the manufacturer
(Amersham Biosciences). Glutathione–agarose was used in
our association assays. The bound GST-fusion proteins
were detected by Coomassie blue staining.
Immunoprecipitation-kinase analysis
Log phase cells were lysed and immunoprecipitated by
incubation with anti-HA antibody and protein A beads. The
IP-kinase assay was performed as described (45). Strains
KSC1333 (MEC1-HA sml1::HIS3), KSC1752 [mec1-
HA(KD) sml1::HIS3], LSS93 (HA-TEL1) and LSS233 [HA-
Tel1(KD)](45,46) were kindly provided by Drs Katsunori
Sugimoto and Akira Matsuura.
In vivo telomerase assay
In vivo telomerase assay was performed as described previ-
ously (47). UCC5706 strain was kindly provided by Dr Daniel
Gottschling. CDC13, cdc13(AA) and cdc13(EE) were gener-
ated by one-step chromosomal insertion using XhoI-digested
pRS304CDC13, pRS304cdc13-AA and pRS304cdc13-EE.
Two-hybrid assay
The two-hybrid assay was performed essentially as described
(48). To construct pACT-POL1, a 1.5 kb DNA fragment
encoding amino acids 47–560 of Pol1p (48) was PCR ampli-
ﬁed. The PCR product was cloned into pGEMTeasy (Pro-
mega). The BamHI/SalI-digested POL1 from pGEMTeasy-
POL1 was inserted into the BamHI/XhoI-digested pACT2.
To construct the full-length CDC13 and cdc13-AA in pAS2,
the NcoI/SalI fragment of CDC13 from pTHA-CDC13 (20)
was inserted into the NcoI/SalI-digested pAS2. Point muta-
tions were introduced into the CDC13 as described above.
Plasmids were transformed into yeast strain Y190 (48). Trans-
formed clones were selected on SC-Leu, SC-Trp plates and
conﬁrmed for interaction on SC-Leu, SC-Trp, SC-His plates
with 3-AT. Fresh transformed colonies of 5–10 were mixed
and spotted in 10-fold serial dilutions onto plates. Plates
were kept at 30 C until colonies formed. Liquid lacZ assays
were done as described in Miller (49) and Guarente (50).
RESULTS
MEC1/TEL1-dependent Cdc13p
phosphorylation in vivo
In order to further understand the biological regulation of
Cdc13p, we ﬁrst investigated whether Cdc13p could be
phosphorylated in vivo. Wild-type yeast cells containing
chromosomal Myc-tagged Cdc13p were subjected to west-
ern blot analysis to detect potential phosphorylation status.
As telomere length was normal in cells expressing this
Myc-tagged protein (data not shown), this tagged gene
was able to provide the telomere functions of Cdc13p.
Western blot analysis showed that levels of Cdc13-Myc
were equivalent in the wild-type, mec1 and tel1strains, but
slightly decreased in the mec1 tel1 strain (Figure 1A). The
migration of Cdc13p bands in gel was slightly faster in the
mec1 tel1 background, suggesting that Cdc13p might be
phosphorylated in a MEC1/TEL1-dependent manner in vivo
(Figure 1A). To test whether Cdc13p is phosphorylated in
vivo, we treated the Myc-antibody precipitated Cdc13p with
phosphatase (PPase). When Cdc13p was treated with calf
intestinal PPase, the smear bands of Cdc13p diminished
(Figure 1B). PPase converted the electrophoretic behavior of
Cdc13p from broad fuzzy bands to a sharp single band with
greater mobility. When lysates were treated with PPase in
the presence of the PPase inhibitor,Cdc13p migrated toa simi-
lar position of the untreated protein (Figure 1B, lane 3).
Because Cdc13p from the mec1 tel1 strain still migrated as
doublets (Figure 1A, lane 4) and the gel mobility of Cdc13p
in the mec1 tel1 strain did not migrate to the same position
as that of PPase-treated wild-type Cdc13p (Figure 1B, lane
2 and data not shown), Cdc13p might be phosphorylated in a
MEC1/TEL1-dependent as well as a MEC1/TEL1-independent
manner in vivo.
Since Cdc13-Myc is a relatively big protein (118 kDa) and
1D gel electrophoresis was hard to clearly resolve the differ-
ence of modiﬁcations in Cdc13p, to gain further insight into
the phosphorylations of Cdc13p by Mec1/Tel kinases, we
separated these modiﬁed Cdc13p by using 2D gel electro-
phoresis. Different forms of Cdc13p were resolved by iso-
electric focusing (pH 4–7 linear gradient) followed by
SDS–PAGE and then detected by western blotting using a
Myc antibody. In addition to the predicted Cdc13p-Myc at
pI 5.31 (spot 2 in Figure 2A), a variant form at pI 5.22
(spot 1) (assuming the linearity of the supplied pH gradient
gels) was observed (Figure 2A). However, in the mec1 tel1
strain, this spot disappeared (Figure 2A). PPase-treatment
also made the spot 1 of Cdc13p of wild-type strain vanished
(Figure 2B). These results suggest that the expression of a
variant Cdc13p was contributed by Mec1/Tel1 kinases-
mediated phosphorylation. Owing to the limited availability
 
 
   
Figure 1. MEC1/TEL1-dependent phosphorylation of Cdc13p in vivo.
(A) Cdc13p phosphorylation was analyzed by western blot analysis. Lysates
from different strains were TCA precipitated for western blot analysis to
detect Cdc13p by a Myc antibody. Pgk1p is the loading control.
(B) Phosphatase treatment of wild-type Cdc13p. Immunoprecipitated Cdc13p
was incubated in PPase buffer, PPase buffer with PPase, or PPase buffer
containing PPase and PPase inhibitors (PI). Western blot analysis was
performed as in (A).
Nucleic Acids Research, 2006, Vol. 34, No. 21 6329of commercial strips for isoelectric focusing gel, we could
not further improve the separation between spot 1 and 2 in
Figure 2. Therefore, we could not rule out the possibility
that there are other variant(s) of Cdc13p between spot
1 and 2 contributed by MEC1/TEL1-dependent as well as
MEC1/TEL1-independent regulation.
The telomerase recruitment domain of Cdc13p is
phosphorylated by Mec1/Tel1 immunoprecipitates
The simplest explanation for the MEC1/TEL1-dependent
Cdc13p phosphorylation is that Cdc13p is directly phospho-
rylated by Mec1p/Tel1p. The ATM/ATR family of kinases
has a preference for phosphorylation of serine in SQ motifs
or threonine in TQ motifs (31). Cdc13p contains 10 such
motifs (Figure 3A). Moreover, these types of S/TQ motifs
are usually located in clusters (31,51). Two such clusters
in Cdc13p were found: one in the telomerase recruitment
domain (RD) (S225, S249, S255 and S306) and the other
in the DNA binding domain (DBD) (S611, S643 and
S652) (Figure 3A). As the ﬁrst step in determining
whether Cdc13p is a substrate of Mec1p/Tel1p, we tested
whether Mec1p/Tel1p could phosphorylate Cdc13p in vitro.
Immunoprecipitated Mec1 and Tel1 kinases were tested
for its ability to phosphorylate Cdc13p. Mec1p and Tel1p
immunoprecipitates were incubated under in vitro kinase
conditions in the presence of [g-
32P]ATP and recombinant
GST-Cdc13(129–332) or GST-Cdc13(570–676) containing
the telomerase recruitment or DNA binding domain, respec-
tively. The reactions were subjected to SDS–PAGE and
autoradiography (Figure 3A). The phosphorylated GST-
Cdc13(129–332) subunit was observed, while neither GST
alone (data not shown) nor the GST-Cdc13(570–676) protein
showed detectable phosphorylation by Mec1p or Tel1p. To
conﬁrm that Mec1 kinase activity was indeed required for
Cdc13 phosphorylation, assays were conducted using extracts
isolated from a mec1 mutant strain. Strain KSC1752 [mec1-
HA(KD)] expresses an HA-tagged Mec1-kd protein with
two amino acid changes in its catalytic domain (52)
(Figure 3A). Based on assays using equivalent amounts of
protein, inactivation of Mec1 kinase activity completely
eliminated Cdc13p phosphorylation. Similar results were
observed by the Tel1 kinase dead protein (52) (Figure 3A).
These results demonstrate that Mec1/Tel1 kinases phosphory-
late the telomerase recruitment domain of Cdc13p.
S225, S249, S255 and S306 are the in vitro
phosphorylation sites of Cdc13p
In order to locate the sites of phosphorylation on Cdc13p,
GST was fused to the amino acids 185–275 and 276–332
of the telomerase recruitment domain of Cdc13p, indepen-
dently. These two recombinant GST-fusion proteins were
then puriﬁed and used as substrates in IP-kinase assays. As
shown in Figure 3B, both GST-fusion proteins were labeled
by Mec1p, but only the 185–275 fragment of Cdc13p was
phosphorylated by Tel1p. There are three SQ sites (residue
225, 249 and 255) within the 185–275 fragment of Cdc13p
and one SQ site (residue 306) within the 276–332 fragment
of Cdc13p. To determine the exact phosphorylation sites,
we puriﬁed mutant GST-Cdc13p containing single, double
or triple serine (S) to alanine (A) mutations at these sites.
These substrates were then used in the IP-kinase assay.
Compared to wild-type Cdc13p, phosphorylation of the triple
mutant Cdc13(185–275) subunit was completely abolished
(Figure 3B). Consistent with the previous results
(Figure 3B), the Cdc13(276–332), but not the Cdc13(276–
332)S306A, was phosphorylated by Mec1p (Figure 2B).
These results indicate that the phosphorylation sites of
Cdc13p by Mec1p are located at amino acids 225, 249,
255 and 306, and the phosphorylation sites of Cdc13p by
Tel1p are located at amino acids 225, 249 and 255. Therefore,
we conclude that S225, S249, S255 and S306 are the major
phosphorylation sites of Cdc13p by Mec1/Tel1 kinases
(Figure 3C).
Phenotypic analysis of cdc13-S mutants
To identify the potential cellular functions for Mec1/Tel1-
mediated phosphorylation of Cdc13p, we tested whether
mutations in these phosphorylation sites would affect the
growth and replication of telomeres. In order to examine
these phenotypes, a strain STY1077 was created in which
the chromosomal CDC13 gene was deleted and was com-
plemented by CDC13 on a single-copy URA3 plasmid
(Figure 4A). STY1077 was transformed with either
Figure 2. 2D gel electrophoresis analysis of Cdc13p. (A) Western blot
analysis of the 2D gel electrophoresis pattern of Cdc13p from wild-type or
mec1 tel1 cells. Immunoprecipitated Cdc13p was subjected to 2D gel
electrophoresis and western blot analysis. The membrane was detected using
a Myc antibody. Area of Cdc13p was enlarged at the bottom. As a merged
control, equal amount of precipitated Cdc13p from wild-type and mec1 tel1
cells were combined prior to protein separation. The different Cdc13p forms
were numbered according to their position relative to the scale of isoelectric
point shifts. (B) Western blot analysis of the 2D gel electrophoresis pattern of
Cdc13p from untreated or PPase-treated wild-type cells. The assay was
performed and presented as in (A).
6330 Nucleic Acids Research, 2006, Vol. 34, No. 21CDC13 or different cdc13-S mutant genes on low-copy
plasmids. Cells carrying cdc13-S mutants were obtained
following selection against the CDC13 plasmid by growth
on 5-FOA. As shown in Figure 4B, single mutations
from S to alanine (A), aspartic acid (D) and glutamic
acid (E) at 249 and 255 all caused telomere shortenings,
indicating that these two residues are important for telom-
ere maintenance. Moreover, while single mutations S225A
and S306A caused no observable telomere and growth
defects, single mutations S249A and S255A maintained
short telomeres stably after several streakings (Figure 4B
and data not shown) and double mutations S249/255AA
resulted in gradual telomere shortening and cellular senes-
cence (Figures 5 and 6). The S225/249/255AAA triple mut-
ant grew poorly even in the ﬁrst restreak (Figure 6) and the
S225/249/255/306AAAA mutant was lethal on the tetradis-
section plates (data not shown). Interestingly, this cellular
senescence of S249/255AA mutant was not observed in
mutation from S to D (S249/255DD) or E (S249/255EE)
(Figure 6). Short telomeres were stably maintained in
these double mutations S249/255DD and S249/255EE
strains (Figure 5 and data not shown), suggesting that
modiﬁed acidic charge residues may partially mimic phos-
phorylation status and suppress the phenotype. The expres-
sion pattern of Cdc13p (Supplementary Figure S1) and the
amount of single-stranded telomeres (Supplementary Figure
S2) of individual mutant in S.cerevisiae are quite similar to
those of wild-type, suggesting that these phenotypic alter-
ations may not be related to protein stability and telomere
binding ability of Cdc13p, respectively. Altogether, these
results highlight the signiﬁcance of these phosphorylation
sites for the telomere replication by the telomerase.
S249 and S255 of Cdc13p are required for
the efficient in vivo action of telomerase
To determine whether these phosphorylations are essential
for the action of telomerase in vivo, we tested the sudden
telomere elongation by the in vivo telomerase assay devel-
oped by Diede and Gottschling (47). Strains were arrested
in M phase by nocadazole treatment, and then subjected to
induction of HO expression. In contrast to wild-type cells
Figure 3. Cdc13p is directly phosphorylated by Mec1p and Tel1p in vitro.( A) Phosphorylation of the telomerase recruitment domain of Cdc13p. Schematic
diagram of Cdc13p illustrates its domain structure and potential S/T phosphorylation sites. GST-fusion proteins to the telomerase recruitment (RD) and DNA
binding (DBD) domains of Cdc13p were purified. Strains KSC1333 (MEC1-HA sml1::HIS3), KSC1752 (mec1-HA(KD) sml1::HIS3), LSS93 (HA-TEL1) and
LSS233 (HA-Tel1(KD)) were lysed, and extracts were immunoprecipitated with anti-HA antibodies. Immunoprecipitated kinases were analyzed by SDS–PAGE
and western blotted with anti-HA antibody (shown at the bottom). IP-kinase assay was performed with GST-Cdc13p(185–332) or GST-Cdc13p(570–676) and
[g-
32P]ATP. Proteins were resolved by SDS–PAGE and the phosphorylated proteins were detected by autoradiography (shown on top). The kinase reactions were
also Coomassie stained (shown below) to confirm that lanes were equally loaded. (B) Mec1p/Tel1p phosphorylation sites in the telomerase recruitment domain of
Cdc13p. The kinase assay was performed as in (A) except that purified GST–Cdc13p(185–275) or GST–Cdc13p(276–332) was included in the kinase reaction.
IP-kinase assays were performed as in (A) using strains KSC1333 (MEC1-HA sml1::HIS3) and LSS93 (HA-TEL1). Schematic diagram of Cdc13p illustrates
the positions of four SQ motifs in the telomerase recruitment domain. Amino acid positions are numbered at the top. Recombinant wild-type and mutant
GST–Cdc13p containing the S to A mutations were used as substrates in the Mec1-HA kinase assay (left) and Tel1-HA kinase assay (right). Asterisks indicate the
complete abolishment of phosphorylation. (C) Summary of the Mec1p and Tel1p phosphorylation sites in the Cdc13p telomerase recruitment domain between
amino acids 129 and 332.
Nucleic Acids Research, 2006, Vol. 34, No. 21 6331Figure 4. Telomere analysis of cdc13-S mutants. (A)Acdc13 strain was constructed that also carried a CDC13 URA3 plasmid. Wild-type or cdc13 mutants on a
CEN TRP1 plasmid were introduced into this strain. Since the drug 5-fluoro orotic acid (5-FOA) kills cells expressing Ura3p, only cells that lost the CDC13
URA3 plasmid will grow on FOA plates. (B) Mec1p/Tel1p phosphorylation sites were mutated from S to alanine (A), aspartic acid (D) and glutamic acid (E). The
telomere lengths were monitored in these cdc13-S mutant strains. DNA from each strain was digested with XhoI, separated in a 1% agarose gel, transferred to a
nylon membrane, and hybridized with a Y0 probe. DNA from the wild-type YPH499 was loaded as a control. Collected yeast cells have lost the CDC13 URA3
plasmid for at least 50 generations.
Figure 5. Telomere analysis of cdc13-S mutants following cell divisions. Assays were conducted as described in Figure 4. The telomere lengths were monitored
in these cdc13-SA and cdc13-SE mutant strains. Genomic DNA from serial liquid dilutions was digested with XhoI, separated in a 1% agarose gel, transferred to a
nylon membrane, and hybridized with a Y0 probe. DNA from the wild-type YPH499 was loaded as a control.
6332 Nucleic Acids Research, 2006, Vol. 34, No. 21which showed telomere elongations at the HO cut site, the
TG1–3/HO end was not elongated in S249/255AA and
S249/255EE cells (Figure 7). These results indicate that
phosphorylation of Cdc13p at amino acids 249 and 255 are
required for the proper in vivo addition of telomeres.
Telomere lengthening by targeted Est1p occurs
efficiently in the absence of the Mec1/Tel1
phosphorylation sites of Cdc13p
We demonstrated that cdc13 phosphorylation mutants
exhibited a strong defect in the telomere length regulation.
Because these phosphorylation sites exist in telomerase
recruit domain, we hypothesized that the recruitment of
telomerase was blocked due to a reduced protein–protein
interaction between Cdc13p and Est1p. We speculated that
the cdc13 mutation would be suppressed if telomeric binding
of Est1p was forced by expression of a hybrid protein con-
sisting of Cdc13p and Est1p. To test this, we examined the
consequences of fusing Cdc13p to Est1p in telomere mainte-
nance. We transformed wild-type and cdc13 cells with the
plasmid pCDC13–EST1 (expressing the Cdc13–Est1 fusion)
(28). Efﬁcient telomere lengthening occurred in the cdc13
mutant (>600 bp) (Figure 8), and the growth defect of
cdc13 mutant cells was suppressed by the transformation of
pCDC13-EST1 or pcdc13-EST1-S249/255AA (data not
shown). This phenotype was observed in every clone that
we analyzed, although in the pcdc13-EST1-S249/255AA con-
taining cells (Figure 7, lane 6) the extent of telomere elonga-
tion was slightly shorter than that in the pCDC13-EST1
containing cells (Figure 7, lane 5). These results conﬁrmed
that the telomere length defect associated with the phospho-
rylation mutation of Cdc13p can be complemented by
targeting Est1p onto the telomere.
Figure 6. Growth of cdc13-S mutants. Spores of each strain were obtained from tetradissection. Each strain was repeatedly streaked on solid YEPD plates and
grown for 3 days at 30 C. Cells from the first four restreaks are shown. It was noticeable that cdc13AA and cdc13AAA spores senesced fast, and S249/255DD or
EE mutations suppressed this phenotype. This suppression was maintained at additional restreaks (data not shown).
Figure 7. Lack of the in vivo telomere addition in cdc13-SA mutants.
UCC5706 cells were introduced with wild-type or cdc13-S mutants. Resulting
strains were arrested using nocodazole. When cells were arrested, galactose
was added to induce HO endonuclease expression. DNA was isolated after 0,
1, 2, 3 and 4 h, and digested with SpeI and analyzed with a fragment that
recognizes sequence distal to the HO recognition site. Telomere addition (*)
was observed in the wild-type, but not in the cdc13AA or EE strain.
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do not affect the Cdc13p–Pol1p interaction
It is possible that the phosphorylation site mutants might be
simply improperly folded or otherwise perturb Cdc13p func-
tions. To demonstrate that some activity of these cdc13
mutants is preserved, we tested the Cdc13p–Pol1p interaction
in cdc13-AA mutants. Cdc13p was shown to interact with
Pol1p, the catalytic subunit of DNA polymerase a (27,48).
Disruption of the activity of the lagging strand DNA replica-
tion machinery leads to unregulated elongation of the G-rich
strand, accompanied by an impaired ability to regulate syn-
thesis of the C-rich strand. (53–55). These data suggested
that DNA polymerase a and Cdc13p play an important
role in the coordination of telomerase action and the replica-
tion of the C-rich strand at chromosome ends. We demon-
strated that Cdc13p interacted with Pol1p in a two-hybrid
assay (Figure 9). Moreover, mutations in the Mec1p/Tel1p
phosphorylation sites did not cause a loss of interaction.
These results indicate that the phosphorylation mutations of
Cdc13p may not perturb the global folding of Cdc13p.
DISCUSSION
The telomerase recruitment function of Cdc13p was previously
demonstrated by expression of a Cdc13p–Est1p or a Cdc13p–
Est2p fusion protein which supplants the need for Est1p in
telomere maintenance (28), Cdc13p–Est1p two-hybrid interac-
tion and other biochemical criteria (24,27). Here we report that
the telomerase recruitment domain of Cdc13p is regulated by
checkpoint kinases Mec1 and Tel1. Blockage of the Mec1p/
Tel1p-mediated phosphorylation in Cdc13p results in an obs-
tacle of telomere lengthening and cell proliferation. Although
it remains possible that these mutations may affect sites of
phosphorylation rather than simply eliminating phosphoryla-
tion sites, our in vitro data prefer the idea that those sites are
direct substrates of Mec1/Tel1 kinases. Interestingly, the
Cdc13p S249/255EE mutant does not display senescence
phenotype (Figure 6), suggesting that the negative charge resi-
dues in these glutamic acids may mimic the Mec1p/Tel1p-
mediated phosphorylation. However, it still exhibits telomere
Figure 8. Telomere lengthening by targeted Est1p in cdc13 cells. Telomere
length was examined in strains of the indicated genotypes carrying a CDC13-
EST1 (lanes 1 and 5), cdc13AA-EST1 (lanes 2 and 6), cdc13EE-EST1 (lane
7), CDC13 (lane 3) or cdc13AA (lane 4) plasmid. These strains were obtained
as described in Figure 3. DNA was prepared at  60 cell divisions after the
loss of the CDC13 URA3 plasmid. DNA from each strain was digested with
XhoI, separated in a 1% agarose gel, transferred on to a nylon membrane, and
hybridized with a Y0 probe.
Figure 9. Interaction of Cdc13p-AA with Pol1p. (A) Yeast cells Y190/
pAS2-1, Y190/pAS2-1-CDC13 or Y190/pAS2-1-cdc13-AA carrying plasmid
pACT2 or pACT2-POL1 were grown on SC medium lacking leucine and
tryptophan at 30 C. Cells were then analyzed by their ability to grow in the
absence of histidine. Ten-fold serial dilution of cells were spotted on glucose
plates either without leucine and tryptophan or without leucine, tryptophan
and histidine and incubated at 30 C until colonies formed. Photographs of the
plates are shown. (B) Extracts were produced from strains expressing both
bait and prey vectors as indicated below. Data are the average of three
independent b-galactosidase measurements. Error bars, SD.
6334 Nucleic Acids Research, 2006, Vol. 34, No. 21shortenings (Figures 4 and 5) and defect of de novo telomere
addition (Figure 7) under our assay condition. One explanation
for these results is that Cdc13–EEp might partially, but not
completely, replace the function of Mec1p/Tel1p-mediated
phosphorylation on Cdc13p.
It was shown previously that a mec1 tel1 strain has an est
phenotype: its telomeres progressively shorten, and mec1 tel1
cells senesce (35). Furthermore, when the Cdc13–Est1p
fusion protein was expressed in mec1 tel1 cells, telomere
length was even longer than in the wild-type strain (23),
which bypass the cellular senescence phenotype of the
mec1 tel1 cells (23). Our results elucidate that the cellular
senescence phenotype of the mec1 tel1 cells was derived
from the lack of phosphorylation of Cdc13p S249 and S255
at the telomerase recruitment domain by Mec1p/Tel1p.
Once this telomerase recruitment function is provided by
the fusion protein, mec1 tel1 cells no longer senesce (23).
Moreover, the reduction of Cdc13p level in mec1 tel1 cells
(Figure 1A) may also partly contribute to the senescent
phenotype.
There is an intriguing correlation between single-strand
DNA binding proteins and checkpoint signaling. For exam-
ple, RPA was shown to be required for the ‘adaptation’
response in the presence of a double strand break (DSB)
(56). Zou and Elledge (57) showed that human ATRIP and
yeast Ddc2 interact directly with RPA-coated ssDNA. Here
we investigated the functional regulation between the check-
point sensor kinases and single-strand telomere binding pro-
tein Cdc13. This study was undertaken since a variety of
experimental results have implicated Mec1p–Tel1p in check-
point control in yeast telomere (23,35–37,46,58). Moreover,
we found previously that Cdc13p and Mec1p–Tel1p are all
involved in telomere–telomere recombination (40). The
sites involved in the Mec1–Tel1-mediated regulation in
Cdc13p are very close to previously determined Cdc
EST site
of Cdc13 (24) further highlighting the importance of this
regulation. The role of Mec1p/Tel1p in the regulation of
Cdc13p at telomeres may be evolutionarily conserved, as
their functional homologues are present in human cells.
The controversy as to when and where Mec1p and Tel1p
act still exists. Theoretically, phosphorylation may also be
possible to be involved in the modiﬁcation of Cdc13p prior
to loading to telomeres. We found that S306 is only phospho-
rylated by Mec1p in vitro. Whether various post-translational
modiﬁcations occur at different cell cycle and whether this
regulates the timing on the action of telomerase remain to
be determined. In addition, we also observed some MEC1/
TEL1-independent phosphorylation of Cdc13p. Whether
these phosphorylations mediate other functions of Cdc13p
and what kinase(s) contribute to MEC1/TEL1-independent
phosphorylation are under investigation.
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